Merck Sale Of Orthopedic Assets Will Grant European Autonomy To Biomet
This article was originally published in The Gray Sheet
Executive Summary
Biomet will redouble European sales and marketing efforts after assuming 100% ownership of its joint venture with Merck KGaA, the firm says
You may also be interested in...
Biomet Shooting For Hip, Knee, Shoulder Indications With Compress System
Biomet will seek additional indications later this year for its recently approved Compress distal femoral replacement system
Biomet Shooting For Hip, Knee, Shoulder Indications With Compress System
Biomet will seek additional indications later this year for its recently approved Compress distal femoral replacement system
Biomet Vanguard Minimally Invasive Knee System To Launch By November
Biomet believes its Vanguard series instrumented, minimally invasive unicondylar knee system will help grow the company's 40% U.S. market share in unicompartmental knees